Kimberly Gentile, VP of Operations at Biohaven Pharmaceutical Holding Co Ltd. (BHVN), sold 3,352 shares at $32.37 ($109K) on 2018-02-01, disclosed to the SEC on 2018-02-02.
Open-market sale of $109k BHVN by VP of Operations. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| BHVN | SELL | 2020-06-17 | $1.7M | — | Filing → |
| BHVN | SELL | 2020-06-10 | $42K | — | Filing → |
| BHVN | SELL | 2019-11-22 | $2.7M | — | Filing → |